These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Radiofrequency ablation for unresectable tumors of the liver. Howard JH, Tzeng CW, Smith JK, Eckhoff DE, Bynon JS, Wang T, Arnoletti JP, Heslin MJ. Am Surg; 2008 Jul 15; 74(7):594-600; discussion 600-1. PubMed ID: 18646476 [Abstract] [Full Text] [Related]
8. Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence. Ayav A, Germain A, Marchal F, Tierris I, Laurent V, Bazin C, Yuan Y, Robert L, Brunaud L, Bresler L. Am J Surg; 2010 Oct 15; 200(4):435-9. PubMed ID: 20409524 [Abstract] [Full Text] [Related]
9. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma. Okuwaki Y, Nakazawa T, Kokubu S, Hidaka H, Tanaka Y, Takada J, Watanabe M, Shibuya A, Minamino T, Saigenji K. Am J Gastroenterol; 2009 Nov 15; 104(11):2747-53. PubMed ID: 19603009 [Abstract] [Full Text] [Related]
18. Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases. Leblanc F, Fonck M, Brunet R, Becouarn Y, Mathoulin-Pélissier S, Evrard S. Eur J Surg Oncol; 2008 Feb 15; 34(2):185-90. PubMed ID: 17998155 [Abstract] [Full Text] [Related]